In Silico Reoptimization of Binding Affinity and Drug-Resistance Circumvention Ability in Kinase Inhibitors: A Case Study With RL-45 and SRC Kinase

doi 10.1021/acs.jpcb.9b02883.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Identifying Novel Targets by Using Drug-Binding Site Signature: A Case Study of Kinase Inhibitors

2019English

Inhibitors of SRC and Focal Adhesion Kinase Promote Endocrine Specification

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma

iScience
Multidisciplinary
2019English

Overcoming Resistance to HER2 Inhibitors Through State-Specific Kinase Binding

Nature Chemical Biology
Cell BiologyMolecular Biology
2016English

Alternaria Toxins as Casein Kinase 2 Inhibitors and Possible Consequences for Estrogenicity: A Hybrid in Silico/in Vitro Study

Archives of Toxicology
MutagenesisToxicologyHealthMedicine
2020English

Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance

Cancers
Cancer ResearchOncology
2018English

SRC Kinase Signaling in Leukaemia

International Journal of Biochemistry and Cell Biology
BiochemistryCell Biology
2007English

Affinity-Based Probes Based on Type II Kinase Inhibitors

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2012English

Anticipating Drug Resistance in the MAP Kinase Pathway

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy